Skip to content
IFAI

AlphaFold

Product11 stories

  1. ResearchReach 31

    DeepMind's playbook to stop AI bioweapons and pandemics

    Google DeepMind and Isomorphic Labs just unveiled a joint bioresilience strategy to tackle biological threats and future outbreaks. Over the past year, they formed over 15 partnerships, deploying tools like AlphaFold, AlphaEvolve, and Isomorphic's drug design engine for pathogen surveillance and vaccine discovery. They are also adapting SynthID watermarking to screen AI-generated biological sequences. Why it matters: As frontier AI lowers the bar for biological modeling, tech giants are racing to build defenses before the risks outpace containment.

  2. IndustryReach 56

    AlphaFold lead John Jumper jumps to Anthropic

    Nobel laureate and AlphaFold pioneer John Jumper just announced he is leaving Google DeepMind after nearly nine years to join Anthropic. Jumper thanked CEO Demis Hassabis for trusting him to lead the protein-folding project fresh out of his PhD, noting he plans to take time to recharge before starting his new role.

  4. IndustryReach 39

    Google DeepMind drops its AGI documentary on YouTube for free

    Google DeepMind just made its feature-length documentary, “The Thinking Game,” free to stream on YouTube to mark AlphaFold's fifth anniversary. Filmed over five years by the crew behind AlphaGo, it follows founder Demis Hassabis and his team as they pursue AGI and crack a 50-year-old biology challenge. It offers a rare, intimate look at the human side of major scientific breakthroughs.

  5. ResearchReach 41

    Stanford builds a virtual lab with AI scientists

    Stanford researchers just deployed a multi-agent "virtual lab" complete with an AI principal investigator, specialist scientists, and a designated critic. Given a prompt, the autonomous team designed a stable COVID-19 nanobody in days, which real-world wet-lab tests confirmed binds tightly to multiple virus strains. Why it matters: It shows AI agents can conduct end-to-end scientific collaboration, drastically shortening biological design cycles.

  6. ResearchReach 31

    Ex-DeepMind scientist launches LatentX for protein design

    Latent Labs just launched LatentX, a web-based AI model that lets researchers design brand-new proteins directly in their browser. Unlike AlphaFold, which predicts existing structures, LatentX generates novel molecules with precise atomic structures to speed up drug discovery. It is currently available for free.

  8. ResearchReach 31

    AI is learning to design life-saving drugs from scratch

    Pharma and tech giants like Eli Lilly and Nvidia see generative AI taking over drug discovery within a few years. By treating molecules and proteins like words in a sentence, AI can generate candidates in minutes that would take labs a year to synthesize, cutting research timelines from years to months. The real bottleneck remains human clinical trials.

  10. ResearchReach 36

    DeepMind's AlphaFold sibling targets genetic disease

    Google DeepMind just unveiled AlphaMissense, an AI model that predicts whether human DNA misspellings are harmless or likely to cause disease. Trained by fine-tuning AlphaFold, it classified 71 million missense mutations to help doctors diagnose rare genetic conditions faster. DeepMind made the predictions freely available, though it held back the full model weights citing biosecurity risks.

  11. IndustryReach 36

    DeepMind's CEO wants AI developers to slow down

    DeepMind CEO Demis Hassabis is urging caution in the race toward AGI, directly pushing back against Facebook's famous mantra to 'move fast and break things.' With emerging risks spanning dangerous chemicals and rogue cyberattacks, Hassabis warns that developers cannot afford to deploy first and clean up the damage later.